Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
Mortality & multi-morbidity
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
H. Julkunen et. al, Nature Communications, 2023
Psychiatric disorders
Interplay of Human Metabolome and Gut Microbiome in Major Depression
N. Amin et. al, 2023
A. Van Der Spek et. al, Human Molecular Genetics, 2021
D. Bizzarri et. al, Bioinformatics, 2022
Genetics, Methods
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
A. Niehues et. al, BMC Genomics, 2022
J. Kiiskilä et. al, BMC Sports Science, Medicine and Rehabilitation, 2022
Ageing & dementia
Longitudinal profiling of metabolic ageing trends in two population cohorts of young adults
V. Mäkinen et. al, International Journal of Epidemiology, 2022
Ageing & dementia
Plasma metabolomics of primary open-angle glaucoma in three prospective US cohorts and the UK Biobank
O. Zeleznik et. al, 2022
Maternal & child health
From menarche to menopause: the impact of reproductive factors on the metabolic profile of over 65,000 women
Inflammation & immunity, Lung disease
Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease
M. Österdahl et. al, Scientific Reports, 2023
K. Suhre et. al, 2022
Cardiovascular disease, Ageing & dementia
Circulating Metabolome and White Matter Hyperintensities in Women and Men
E. Sliz et. al, Circulation, 2022
F. Bragg et. al, Diabetes Care, 2021
Cardiovascular disease, Inflammation & immunity
Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young
S. Chiesa et. al, Journal of the American Heart Association, 2022
Cardiovascular disease
What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling
T. Melnes et. al, Nutrition, Metabolism and Cardiovascular Diseases, 2022